|
CBX5 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 8.962400E-03 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
7.001900E-02 |
| Normal-vs-Stage2 |
3.282800E-01 |
| Normal-vs-Stage3 |
1.467220E-01 |
| Normal-vs-Stage4 |
4.993200E-01 |
| Stage1-vs-Stage2 |
9.711600E-01 |
| Stage1-vs-Stage3 |
5.888800E-01 |
| Stage1-vs-Stage4 |
8.361200E-01 |
| Stage2-vs-Stage3 |
6.932200E-01 |
| Stage2-vs-Stage4 |
8.572000E-01 |
| Stage3-vs-Stage4 |
9.148400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.042300E-02 |
| Normal-vs-AfricanAmerican |
3.010300E-02 |
| Normal-vs-Asian |
1.220410E-01 |
| Caucasian-vs-AfricanAmerican |
6.184400E-01 |
| Caucasian-vs-Asian |
1.246020E-01 |
| AfricanAmerican-vs-Asian |
9.104400E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.673600E-02 |
| Normal-vs-Female |
1.084310E-02 |
| Male-vs-Female |
3.028000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
3.999400E-01 |
| Normal-vs-Extreme_Weight |
3.454200E-01 |
| Normal-vs-Obese |
3.381000E-03 |
| Normal-vs-Extreme_Obese |
9.276400E-01 |
| Normal_Weight-vs-Extreme_Weight |
9.463400E-01 |
| Normal_Weight-vs-Obese |
8.564000E-02 |
| Normal_Weight-vs-Extreme_Obese |
6.081200E-01 |
| Extreme_Weight-vs-Obese |
3.364100E-02 |
| Extreme_Weight-vs-Extreme_Obese |
6.238800E-01 |
| Obese-vs-Extreme_Obese |
1.442780E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.110590E-01 |
| Normal-vs-Age(41-60Yrs) |
5.028100E-04 |
| Normal-vs-Age(61-80Yrs) |
2.990200E-01 |
| Normal-vs-Age(81-100Yrs) |
8.636400E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.003400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.055400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.624400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.738800E-03 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.516220E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.310600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.284420E-03 |
| Normal-VS-Type2 PRCC |
6.518600E-01 |
| Normal-VS-KIRP CIMP |
8.252000E-01 |
| Normal-VS-Unclassified PRCC |
9.464300E-03 |
| Type1 PRCC-VS-Type2 PRCC |
1.845970E-02 |
| Type1 PRCC-VS-KIRP CIMP |
2.481400E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
2.532400E-01 |
| Type2 PRCC-VS-KIRP CIMP |
9.445400E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
2.372300E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
6.018200E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
9.630600E-01 |
| Normal-vs-N1 |
6.896000E-02 |
| Normal-vs-N2 |
1.498070E-02 |
| N0-vs-N1 |
7.720500E-02 |
| N0-vs-N2 |
1.273010E-01 |
| N1-vs-N2 |
7.768000E-01 |
|
|
